Entrada Therapeutics, Inc. SEC filings TRDA

Entrada Therapeutics, Inc. has 472 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Feb 26, 2026 —
S-3 Shelf registration Nov 6, 2025 —
S-8 Employee stock plan registration Mar 25, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
424B5 Prospectus supplement Jun 24, 2024 —
S-8 Employee stock plan registration Mar 13, 2024 —
424B5 Prospectus supplement Sep 29, 2023 —
S-8 Employee stock plan registration Mar 6, 2023 —
S-3 Shelf registration Nov 1, 2022 —
S-8 Employee stock plan registration Mar 15, 2022 —
424B4 Prospectus Nov 1, 2021 —
S-1MEF Form s-1mef Oct 28, 2021 —
S-8 Employee stock plan registration Oct 28, 2021 —
S-1/A Amended registration statement Oct 25, 2021 —
S-1 Registration statement Oct 8, 2021 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TRDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
, Emerging growth company
SEC CIK
1689375
Former names
CycloPorters, Inc. (until Nov 10, 2016)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.